Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Montana Governor Wants to Import Drugs from Canada

By Pharmaceutical Processing | March 12, 2010

HELENA, Mont. (AP) — Gov. Brian Schweitzer said Thursday that he is seeking federal permission to import cheaper drugs from Canada for use in state insurance programs.

Schweitzer said he thinks the move could chop 40 percent off the $100 million the state spends each year on prescription drugs for Medicaid, the children’s health insurance program, state employees, and inmates at the prison.

“We know we can save a lot of money,” Schweitzer said.

The governor said he envisions the state setting up a deal with a Canadian wholesaler that could mail the drugs to local pharmacies on insurance plans paid for by the state. In the case of the prison, the governor said he expects the state would order those directly.

The U.S. Centers for Medicare and Medicaid Services said Thursday it had not yet seen Montana’s request and couldn’t comment.

Schweitzer was first involved in the issue during an unsuccessful U.S. Senate run in 2000, when he made cheap Canadian drugs a cornerstone of his platform and would take busloads of seniors north of the border to buy drugs.

The issue has been debated in Washington, D.C., over the years.

Recently, the U.S. Senate rejected a plan to let Americans import prescription drugs from abroad. Such a change would deprive drug makers of billions of dollars.

Both the pharmaceutical industry and the Obama administration also have argued that such plans would not protect people from potentially dangerous or ineffective drugs — a notion at which Schweitzer and other supporters scoff.

“These are the same drugs from the same places,” Schweitzer said of the Canadian pharmaceuticals.

Schweitzer is asking Health and Human Services Secretary Kathleen Sebelius to exercise authority to certify the drugs to be safe, to waive Medicaid requirements that such funds only be spent within U.S. borders, and to make other allowances.

Schweitzer said he decided to move forward with the idea now because Congress has not solved the problem with health care reform and because the state is desperately looking for ways to cut costs.

“Desperate times make us desperate people,” Schweitzer said.

The governor said he hopes for a waiver within the year.

 

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards